Announcement under Regulation 30 (LODR)-Investor Presentation
Filed with BSE · ISIN INE00TV01023 · · 48 pages · English
Summary by 6ix AI
Sudarshan Pharma Industries Ltd has submitted an updated Investor Presentation as part of its disclosure obligations under the SEBI regulations. It also outlines the company's strategic focus on expanding its API product range and targeting regulated markets for future growth. Additionally, the presentation emphasizes the company's commitment to quality and operational excellence, supported by recent global certifications.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Sudarshan Pharma Industries Ltd on 6ix
In the deck
Story so far
Earlier from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement under Regulation 30 (LODR)-Issue of Securities
- Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday, 29Th October, 2026
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries